1. |
1 譚廣, 任金帥, 王忠裕, 等. TNF-α增強樹突狀細胞誘導的抗胰腺癌免疫應答的實驗研究 [J] . 中國普外基礎與臨床雜志, 2006; 13(6):689
2 嚴茂林, 程南生. 樹突狀細胞與消化系惡性腫瘤預后的研究進展 [J] . 中國普外基礎與臨床雜志, 2003; 10(5):519.
|
2. |
Steinman RM, Pack M, Inaba K. Dendritic cells in the T-cell areas of lymphoid organs [J] . Immunol Rev, 1997; 156:25.
|
3. |
Lodge PA, Jones LA, Bader RA, et al . Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase Ⅱ clinical trial [J] . Cancer Res, 2000; 60(4):829.
|
4. |
Bell D, Young JW, Banchereau J. Dendritic cells [J] . Adv Immunol, 1999; 72:255.
|
5. |
Nouri-Shirazi M, Banchereau J, Fay J, et al . Dendritic cell based tumor vaccines [J] . Immunol Lett, 2000; 74(1):5.
|
6. |
Miller PW, Sharma S, Stolina M, et al . Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication [J] . Hum Gene Ther, 2000; 11(1):53.
|
7. |
Celluzzi CM, Falo LD Jr. Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection [J] . J Immunol, 1998; 160(7):3081.
|
8. |
Fong L, Brockstedt D, Benike C, et al . Dendritic cells injected via different routes induce immunity in cancer patients [J] . J Immunol, 2001; 166(6):4254.
|
9. |
張艷林, 薛剛. 腫瘤細胞裂解物致敏的樹突狀細胞對肝癌HepG2細胞殺傷的體外研究 [J] . 華西醫學, 2007; 22(1):18.
|